Wellness Behavioral Health, Llc | |
7625 Hospital Dr Dublin OH 43016-9649 | |
(614) 819-3463 | |
Not Available |
Full Name | Wellness Behavioral Health, Llc |
---|---|
Speciality | Psychiatry & Neurology |
Location | 7625 Hospital Dr, Dublin, Ohio |
Authorized Official Name and Position | Shamsun Nahar (CEO) |
Authorized Official Contact | 6147960327 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Wellness Behavioral Health, Llc Po Box 3577 Dublin OH 43016-0289 Ph: (614) 796-0327 | Wellness Behavioral Health, Llc 7625 Hospital Dr Dublin OH 43016-9649 Ph: (614) 819-3463 |
NPI Number | 1114492949 |
---|---|
Provider Enumeration Date | 10/08/2018 |
Last Update Date | 01/26/2021 |
Certification Date | 08/27/2020 |
Medicare PECOS PAC ID | 6406190099 |
---|---|
Medicare Enrollment ID | O20181210000238 |
News Archive
Adults who experienced multiple incidents of childhood maltreatment were more than two times as likely to have trouble sleeping than their counterparts who were not maltreated during childhood, according to a new study from researchers at the University of Toronto, University of Ottawa, and Western University.
Tetraphase Pharmaceuticals Inc., a biopharmaceutical company capitalizing on breakthrough synthetic chemistry technology announced today that it will present three (3) posters and deliver a slide presentation on the synthesis and antibacterial activity of analogs from several novel classes of antibiotics to treat drug-resistant infections at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.
Researchers from the Lisbon School of Medicine, University of Lisbon found that, in some mild cognitive impairment patients, real neuropsychological stability over a decade is possible and that long-term stability could be predicted based on neuropsychological tests measuring memory and non-verbal abstract reasoning.
Impax Laboratories, Inc. today reported significant growth in the first quarter of 2010 due to an increase in sales from its Global product sales channel. Total revenue increased $264.4 million to $323.3 million driven by the successful March 2 exclusive launch of generic Flomax® ($176.2 million of revenue and $167.9 million of gross profit) and continued strong sales of generic Adderall XR® for which there were no comparable amounts in the first quarter 2009, as well as increased sales of the Company's fenofibrate products.
› Verified 4 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1114492949 | NPI | - | NPPES |
2854764 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | (* (Not Available)) | Primary |
Provider Name | Shamsun Nahar |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1972644235 PECOS PAC ID: 6709986904 Enrollment ID: I20070717000005 |
News Archive
Adults who experienced multiple incidents of childhood maltreatment were more than two times as likely to have trouble sleeping than their counterparts who were not maltreated during childhood, according to a new study from researchers at the University of Toronto, University of Ottawa, and Western University.
Tetraphase Pharmaceuticals Inc., a biopharmaceutical company capitalizing on breakthrough synthetic chemistry technology announced today that it will present three (3) posters and deliver a slide presentation on the synthesis and antibacterial activity of analogs from several novel classes of antibiotics to treat drug-resistant infections at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.
Researchers from the Lisbon School of Medicine, University of Lisbon found that, in some mild cognitive impairment patients, real neuropsychological stability over a decade is possible and that long-term stability could be predicted based on neuropsychological tests measuring memory and non-verbal abstract reasoning.
Impax Laboratories, Inc. today reported significant growth in the first quarter of 2010 due to an increase in sales from its Global product sales channel. Total revenue increased $264.4 million to $323.3 million driven by the successful March 2 exclusive launch of generic Flomax® ($176.2 million of revenue and $167.9 million of gross profit) and continued strong sales of generic Adderall XR® for which there were no comparable amounts in the first quarter 2009, as well as increased sales of the Company's fenofibrate products.
› Verified 4 days ago
News Archive
Adults who experienced multiple incidents of childhood maltreatment were more than two times as likely to have trouble sleeping than their counterparts who were not maltreated during childhood, according to a new study from researchers at the University of Toronto, University of Ottawa, and Western University.
Tetraphase Pharmaceuticals Inc., a biopharmaceutical company capitalizing on breakthrough synthetic chemistry technology announced today that it will present three (3) posters and deliver a slide presentation on the synthesis and antibacterial activity of analogs from several novel classes of antibiotics to treat drug-resistant infections at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.
Researchers from the Lisbon School of Medicine, University of Lisbon found that, in some mild cognitive impairment patients, real neuropsychological stability over a decade is possible and that long-term stability could be predicted based on neuropsychological tests measuring memory and non-verbal abstract reasoning.
Impax Laboratories, Inc. today reported significant growth in the first quarter of 2010 due to an increase in sales from its Global product sales channel. Total revenue increased $264.4 million to $323.3 million driven by the successful March 2 exclusive launch of generic Flomax® ($176.2 million of revenue and $167.9 million of gross profit) and continued strong sales of generic Adderall XR® for which there were no comparable amounts in the first quarter 2009, as well as increased sales of the Company's fenofibrate products.
› Verified 4 days ago
The People Institute, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5900 Sawmill Rd, Suite 210, Dublin, OH 43017 Phone: 614-717-9652 Fax: 614-717-9657 | |
Nelsen Counseling Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6047 Frantz Rd Ste 205, Dublin, OH 43017 Phone: 614-401-6203 | |
Stephanie E Wilson Lisw-s Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 90 S High St Ste E, Dublin, OH 43017 Phone: 614-579-9657 | |
Done Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 545 Metro Pl S Ste 100, Dublin, OH 43017 Phone: 888-291-5143 | |
Ketamine Health & Wellness Clinics Of Ohio Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5060 Bradenton Ave Ste A, Dublin, OH 43017 Phone: 380-214-1636 Fax: 380-235-7469 | |
Emerald Psychiatry & Tms Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 495 Metro Pl S Ste 160, Dublin, OH 43017 Phone: 614-580-6917 | |
Growing Together Therapy Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 555 Metro Pl N Ste 560, Dublin, OH 43017 Phone: 614-321-5191 |